- GlobeNewswire•18 hours ago
MELBOURNE, Australia, Jan. 19, 2017-- Australian biopharmaceutical Company Immuron Limited is pleased to announce the initiation of several studies designed to add to the growing body of evidence supporting ...
- GlobeNewswire•2 days ago
MELBOURNE, Australia, Jan. 18, 2017-- Immuron Limited wishes to advise investors that European and US-based Life Sciences Research and Analyst firm Van Leeuwenhoeck Institute, has released a Research Note ...
- GlobeNewswire•14 days ago
MELBOURNE, Australia, Jan. 06, 2017-- Following the US $1.7 B proposed takeover of Tobira by Allergan, three more Licensing Mergers & Acquisitions transactions over the past two months, continue to highlight ...
IMC.AX : Summary for IMMURON FPO - Yahoo Finance
Immuron Limited (IMC.AX)
ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
|Day's Range||0.30 - 0.31|
|52 Week Range||0.22 - 0.45|
|PE Ratio (TTM)||-5.35|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|